Ratings by Alliance Global Partners (Ben Haynor)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2023 | Evogene Ltd | EVGN | New Coverage | Buy (N/A) |
0.59 (0.44) |
-25.42% | Details | |
| 9/8/2023 | Nano-X Imaging | NNOX | New Coverage | Buy (N/A) |
7.66 (1.57) |
-79.5% | Details | |
| 8/22/2023 | Aspira Women’s Health | AWH | New Coverage | Buy (N/A) |
2.76 (0.08) |
-97.1% | Details | |
| 7/7/2022 | T2 Biosystems, Inc | TTOO | Downgrade | Neutral (Buy) |
0.16 (0.13) |
-18.75% | Details | |
| 5/13/2022 | DarioHealth Corp. | DRIO | Upgrade | Buy (Neutral) |
5.18 (6.06) |
16.99% | Details | |
| 2/18/2022 | T2 Biosystems, Inc | TTOO | Upgrade | Buy (Neutral) |
0.40 (0.13) |
-67.5% | Details | |
| 8/23/2021 | Kindred Biosciences | KIN | Downgrade | Neutral (Buy) |
9.23 (9.25) |
0.22% | Details | |
| 8/19/2021 | IMAC, Holdings Inc. | IMAC | Downgrade | Neutral (Buy) |
1.48 (1.01) |
-31.76% | Details | |
| 8/17/2021 | Eyegate Pharmaceuticals | EYEG | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2021 | Myomo Inc. | MYO | New Coverage | Buy (N/A) |
10.19 (1.18) |
-88.42% | Details | |
| 5/12/2021 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2021 | Take-Two Interactive | TTOO | Downgrade | Neutral (Buy) |
199.78 (0.13) |
-99.93% | Details | |
| 11/17/2020 | IMAC, Holdings Inc. | IMAC | New Coverage | Buy (N/A) |
1.05 (1.48) |
40.95% | Details | |
| 7/21/2020 | Eyegate Pharmaceuticals | EYEG | New Coverage | Buy (N/A) |
4.87 (35.41) |
627.1% | Details | |
| 5/10/2019 | Sensus Healthcare | SRTS | Downgrade | Neutral (Buy) |
6.38 (4.62) |
-27.59% | Details | |
| 3/26/2019 | DarioHealth Corp. | DRIO | Maintain | Buy (N/A) |
|
Details |
